taxonomy (10)
protein (15)
source (21)
structure (27)
composition (1)
disease (7)
reference (24)
site (19)
peptide (4)
- Homo sapiens (Human)
- Macaca radiata (Bonnet macaque)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Bufo bufo (European toad)
- Rana clamitans (Green frog)
- Xenopus tropicalis (Western clawed frog)
- Lycopersicon esculentum (Tomato)
- Drosophila melanogaster (Fruit fly)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- CD59 glycoprotein / Homo sapiens P13987
- Glycoprotein rg / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens P01859
- Kappa casein / Homo sapiens P07498
- Non-secretory ribonuclease / Homo sapiens P10153
- Unspecified mucin / Homo sapiens
- Uromodulin / Homo sapiens P07911
- Mucin / Macaca radiata
- Mucin / Rattus norvegicus
- Mucin-2 glycopeptide a / Rattus norvegicus Q62635
- Mucin-2 glycopeptide b / Rattus norvegicus Q62635
- Mucin / Sus scrofa
- Mucin / Bufo bufo
- Mucin / Rana clamitans
- Mucin / Xenopus tropicalis
Protein
- Blood Plasma (UBERON_0001969)
- Cervical Mucosa (UBERON_0012248)
- Duodenal Gland (UBERON_0001212)
- Embryo (UBERON_0000922)
- Large Intestine (UBERON_0000059)
- Liver (UBERON_0002107)
- Milk (UBERON_0001913)
- Mucosa of Stomach (UBERON_0001199)
- Ovary (UBERON_0000992)
- Pulmonary Mucosa
- Saliva (UBERON_0001836)
- Small Intestine (UBERON_0002108)
- Spleen (UBERON_0002106)
- Stomach (UBERON_0000945)
- Tracheal Mucosa (UBERON_0000379)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
- C10 (CVCL_5245)
- SW48 (CVCL_1724)
- Egg Cell Jelly Coat
- Pericarp (BTO_0001017)
Source
- N-Linked / Complex / Structure 10936
- N-Linked / Hybrid / Structure 9843
- N-Linked / No-core / GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / No-core / GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- O-Linked / Core 1 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-?)GlcNAc(b1-3)Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-3)GlcNAc(b1-6)[GalNAc(b1-3)Gal(b1-3)]Gal(b1-3)GalNAc
- O-Linked / Core 2 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[GlcNAc(b1-4)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)[GlcNAc(a1-4)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-3)GalNAc(b1-6)[Gal(b1-3)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-4)GlcNAc(b1-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-4)GlcNAc(b1-6)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(a1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / GalNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Core 2 / GlcNAc(a1-4)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Structure 11036
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-3)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-3)]GalNAc
- O-Linked / Undefined core / Fuc(?1-2)[GalNAc(?1-3)]Gal(?1-?)GlcNAc(?1-?)Gal(?1-3)GalNAc
- O-Linked / Undefined core / Fuc(?1-2)[GlcNAc(?1-3)]Gal(?1-3)GlcNAc(?1-6)[Gal(?1-3)]GalNAc
- O-Linked / Undefined core / Fuc(?1-2)Gal(?1-?)GlcNAc(?1-6)[Gal(?1-?)GlcNAc(?1-3)]GalNAc
Reported structure
- Hex:2 HexNAc:3 dHex:1 (avg mass : 1098.0281 )
Composition
- Bronchiectasis, due to Kartagener's Syndrome
- Cancer, Ovarian (Cystic) (DOID:2394)
- Colon adenocarcinoma (DOID:234)
- COVID-19 (DOID:0080600)
- Cystic Fibrosis (DOID:1485)
- Multiple myeloma (DOID:9538)
- Prostate cancer (DOID:10283)
Disease
- Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype (2021 - Katarina Madunić, Tao Zhang, Oleg A Mayboroda, Stephanie Holst, Kathrin Stavenhagen, Chunsheng Jin, Niclas G Karlsson, Guinevere S M Lageveen-Kammeijer, Manfred Wuhrer) / Status : Reviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Dynamic Developmental Elaboration of N-Linked Glycan Complexity in the Drosophila melanogaster Embryo (2007 - Kazuhiro Aoki, Mindy Perlman, Jae-Min Lim, Rebecca Cantu, Lance Wells, Michael Tiemeyer) / Status : Reviewed
- Identification of the blood group Lewis(a) determinant in the oviducal mucins of Xenopus tropicalis. (2003 - Guérardel Y, Petit D, Madigou T, Guillet B, Maes E, Maftah A, Boujard D, Strecker G, Kol O) / Status : Reviewed
- Species specificity of O-linked carbohydrate chains of the oviducal mucins in amphibians: structural analysis of neutral oligosaccharide alditols released by reductive beta-elimination from the egg-jelly coats of Rana clamitans. (2002 - Delplace F, Maes E, Lemoine J, Strecker G) / Status : Reviewed
- Structural analysis of oligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo: characterization of the carbohydrate sequence Gal(alpha1-3)GalNAc(alpha1-3)[Fuc(alpha1-2)]Gal. (1997 - Morelle W, Strecker G) / Status : Reviewed
- The glycosylation of rat intestinal Muc2 mucin varies between rat strains and the small and large intestine. A study of O-linked oligosaccharides by a mass spectrometric approach. (1997 - Karlsson N, Herrmann A, Karlsson H, Johansson M, Carlstedt I, Hansson G) / Status : Reviewed
- Structural analysis of hexa to dodecaoligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo. (1997 - Morelle W, Strecker G) / Status : Reviewed
- Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. (1996 - Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K) / Status : Reviewed
- Characterization of two different glycosylated domains from the insoluble mucin complex of rat small intestine. (1993 - Carlstedt I, Herrmann A, Karlsson H, Sheehan J, Fransson L, Hansson G) / Status : Reviewed
- Human non-secretory ribonucleases. II. Structural characterization of the N-glycans of the kidney, liver and spleen enzymes by NMR spectroscopy and electrospray mass spectrometry. (1993 - Lawrence C, Little P, Little B, Glushka J, van Halbeek H, Alhadeff J) / Status : Reviewed
- Structure of ten free N-glycans in ripening tomato fruit. Arabinose is a constituent of a plant N-glycan. (1993 - Priem B, Gitti R, Bush C, Gross K) / Status : Reviewed
- Studies on cervical glycoproteins: isolation and characterisation of oligosaccharides from luteal phase cervical glycoproteins of bonnet monkey. (1993 - Nasir-Ud-Din , Walker-Nasir E, Fayyaz-Ud-Din) / Status : Reviewed
- The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins. (1992 - Klein A, Carnoy C, Wieruszeski J, Strecker G, Strang A, van Halbeek H, Roussel P, Lamblin G) / Status : Reviewed
- Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins. (1992 - Sangadala S, Bhat U, Mendicino J) / Status : Reviewed
- Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 2. Structure of 19 oligosaccharides having the GlcNAc beta(1----3)GalNAc-ol (1988 - Breg J, Van Halbeek H, Vliegenthart J, Klein A, Lamblin G, Roussel P) / Status : Reviewed
- Chemical structure of neutral sugar chains isolated from human mature milk kappa-casein. (1988 - Saito T, Itoh T, Adachi S) / Status : Reviewed
- Characterization of the oligosaccharide alditols from ovarian cyst mucin glycoproteins of blood group A using high pressure liquid chromatography (HPLC) and high field 1H NMR spectroscopy. (1986 - Dua VK, Rao BN, Wu SS, Dube VE, Bush CA) / Status : Reviewed
- Purification and structures of oligosaccharide chains in swine trachea and Cowper's gland mucin glycoproteins. (1984 - Rana SS, Chandrasekaran EV, Kennedy J, Mendicino J) / Status : Reviewed
- Further characterization, by a combined high-performance liquid chromatography/1H-NMR approach, of the heterogeneity displayed by the neutral carbohydrate chains of human bronchial mucins. (1984 - Lamblin G, Boersma A, Lhermitte M, Roussel P, Mutsaers J, van Halbeek H, Vliegenthart J) / Status : Reviewed
- Structures of the neutral oligosaccharides isolated from A-active human gastric mucin. (1984 - Slomiany A, Zdebska E, Slomiany BL) / Status : Reviewed
- Terminal alpha (1 leads to 4)-linked N-acetylglucosamine: a characteristic constituent of duodenal-gland mucous glycoproteins in rat and pig. A high-resolution 1H-NMR study. (1983 - van Halbeek H, Gerwig G, Vliegenthart J, Smits H, Van Kerkhof P, Kramer M) / Status : Reviewed
Reference
- CD59 glycoprotein / Homo sapiens
-
Glycoprotein rg / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Undefined site
-
Kappa casein / Homo sapiens
- Undefined site
-
Non-secretory ribonuclease / Homo sapiens
- Undefined site
-
Unspecified mucin / Homo sapiens
- Undefined site
- Uromodulin / Homo sapiens
-
Mucin / Macaca radiata
- Undefined site
-
Mucin / Rattus norvegicus
- Undefined site
-
Mucin-2 glycopeptide a / Rattus norvegicus
- Undefined site
-
Mucin-2 glycopeptide b / Rattus norvegicus
- Undefined site
-
Mucin / Sus scrofa
- Undefined site
-
Mucin / Bufo bufo
- Undefined site
-
Mucin / Rana clamitans
- Undefined site
-
Mucin / Xenopus tropicalis
- Undefined site
Reported glycosite
- HAIHVSGTNGTK (12aa)
- DLCNFNEQLENGGTSLSEK (19aa)
- ACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCKSNNGR (47aa)
- FALLMTNCYATPSSNATDPLKYFIIQDR (28aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1098.0281)
- Blood Plasma (UBERON_0001969)
- Multiple myeloma (DOID:9538)
-
Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1098.0281)
- Embryo (UBERON_0000922)
-
- N-Linked / No-core
(avg mass : 1098.0281)
- Pericarp (BTO_0001017)
-
- N-Linked / No-core
(avg mass : 1098.0281)
-
Non-secretory ribonuclease / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1098.0281)
- Stomach (UBERON_0000945)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 1098.0281)
- Egg Cell Jelly Coat
-
Mucin / Rana clamitans
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Cancer, Ovarian (Cystic) (DOID:2394)
- Characterization of the oligosaccharide alditols from ovarian cyst mucin glycoproteins of blood group A using high pressure liquid chromatography (HPLC) and high field 1H NMR spectroscopy. (1986 - Dua VK, Rao BN, Wu SS, Dube VE, Bush CA) / Status : Reviewed
- Structures of the neutral oligosaccharides isolated from A-active human gastric mucin. (1984 - Slomiany A, Zdebska E, Slomiany BL) / Status : Reviewed
-
Glycoprotein rg / Homo sapiens
- Undefined site
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins. (1992 - Sangadala S, Bhat U, Mendicino J) / Status : Reviewed
- Characterization of the oligosaccharide alditols from ovarian cyst mucin glycoproteins of blood group A using high pressure liquid chromatography (HPLC) and high field 1H NMR spectroscopy. (1986 - Dua VK, Rao BN, Wu SS, Dube VE, Bush CA) / Status : Reviewed
-
Glycoprotein rg / Homo sapiens
- Undefined site
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Cervical Mucosa (UBERON_0012248)
-
Mucin / Macaca radiata
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. (1996 - Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K) / Status : Reviewed
- Terminal alpha (1 leads to 4)-linked N-acetylglucosamine: a characteristic constituent of duodenal-gland mucous glycoproteins in rat and pig. A high-resolution 1H-NMR study. (1983 - van Halbeek H, Gerwig G, Vliegenthart J, Smits H, Van Kerkhof P, Kramer M) / Status : Reviewed
-
Mucin / Rattus norvegicus
- Undefined site
-
Mucin / Sus scrofa
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Egg Cell Jelly Coat
-
Mucin / Rana clamitans
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Milk (UBERON_0001913)
-
Kappa casein / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Milk (UBERON_0001913)
-
Kappa casein / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Egg Cell Jelly Coat
- Identification of the blood group Lewis(a) determinant in the oviducal mucins of Xenopus tropicalis. (2003 - Guérardel Y, Petit D, Madigou T, Guillet B, Maes E, Maftah A, Boujard D, Strecker G, Kol O) / Status : Reviewed
- Structural analysis of oligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo: characterization of the carbohydrate sequence Gal(alpha1-3)GalNAc(alpha1-3)[Fuc(alpha1-2)]Gal. (1997 - Morelle W, Strecker G) / Status : Reviewed
- Structural analysis of hexa to dodecaoligosaccharide-alditols released by reductive beta-elimination from oviducal mucins of Bufo bufo. (1997 - Morelle W, Strecker G) / Status : Reviewed
-
Mucin / Bufo bufo
- Undefined site
-
Mucin / Xenopus tropicalis
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Egg Cell Jelly Coat
-
Mucin / Rana clamitans
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Duodenal Gland (UBERON_0001212)
-
Mucin / Rattus norvegicus
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- Tracheal Mucosa (UBERON_0000379)
-
Mucin / Sus scrofa
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1098.0281)
- C10 (CVCL_5245)
- SW48 (CVCL_1724)
- Colon adenocarcinoma (DOID:234)
-
- O-Linked / Core 4
(avg mass : 1098.0281)
- The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins. (1992 - Klein A, Carnoy C, Wieruszeski J, Strecker G, Strang A, van Halbeek H, Roussel P, Lamblin G) / Status : Reviewed
- Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 2. Structure of 19 oligosaccharides having the GlcNAc beta(1----3)GalNAc-ol (1988 - Breg J, Van Halbeek H, Vliegenthart J, Klein A, Lamblin G, Roussel P) / Status : Reviewed
- Further characterization, by a combined high-performance liquid chromatography/1H-NMR approach, of the heterogeneity displayed by the neutral carbohydrate chains of human bronchial mucins. (1984 - Lamblin G, Boersma A, Lhermitte M, Roussel P, Mutsaers J, van Halbeek H, Vliegenthart J) / Status : Reviewed
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4
(avg mass : 1098.0281)
- Pulmonary Mucosa
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4
(avg mass : 1098.0281)
- Pulmonary Mucosa
- Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 2. Structure of 19 oligosaccharides having the GlcNAc beta(1----3)GalNAc-ol (1988 - Breg J, Van Halbeek H, Vliegenthart J, Klein A, Lamblin G, Roussel P) / Status : Reviewed
- Further characterization, by a combined high-performance liquid chromatography/1H-NMR approach, of the heterogeneity displayed by the neutral carbohydrate chains of human bronchial mucins. (1984 - Lamblin G, Boersma A, Lhermitte M, Roussel P, Mutsaers J, van Halbeek H, Vliegenthart J) / Status : Reviewed
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4
(avg mass : 1098.0281)
- Saliva (UBERON_0001836)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4
(avg mass : 1098.0281)
- Saliva (UBERON_0001836)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Core 4
(avg mass : 1098.0281)
- Saliva (UBERON_0001836)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- O-Linked / Undefined core
(avg mass : 1098.0281)
- Large Intestine (UBERON_0000059)
-
Mucin-2 glycopeptide a / Rattus norvegicus
- Undefined site
-
- O-Linked / Undefined core
(avg mass : 1098.0281)
- Large Intestine (UBERON_0000059)
-
Mucin-2 glycopeptide a / Rattus norvegicus
- Undefined site
-
- O-Linked / Undefined core
(avg mass : 1098.0281)
- Small Intestine (UBERON_0002108)
-
Mucin-2 glycopeptide a / Rattus norvegicus
- Undefined site
-
Mucin-2 glycopeptide b / Rattus norvegicus
- Undefined site
-
- Hex:2 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1098.0281)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Complex / Structure 10936
- N-Linked / Hybrid / Structure 9843
- N-Linked / No-core / GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / No-core / GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- COVID-19 (DOID:0080600)
- HAIHVSGTNGTK (12aa)
-
- Hex:2 HexNAc:3 dHex:1 / O-Linked
(avg mass : 1098.0281)
- Urine (UBERON_0001088)
- O-Linked / Core 1 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-?)GlcNAc(b1-3)Gal(b1-3)GalNAc
- O-Linked / Core 1 / Fuc(a1-3)GlcNAc(b1-6)[GalNAc(b1-3)Gal(b1-3)]Gal(b1-3)GalNAc
- O-Linked / Core 2 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-3)[GlcNAc(b1-4)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)[GlcNAc(a1-4)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Fuc(a1-3)GalNAc(b1-6)[Gal(b1-3)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-4)GlcNAc(b1-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Fuc(a1-4)GlcNAc(b1-6)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Gal(a1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)[GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / GalNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Core 2 / GlcNAc(a1-4)Gal(b1-4)GlcNAc(b1-6)[Fuc(a1-2)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Structure 11036
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 4 / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-3)GlcNAc(b1-3)]GalNAc
- O-Linked / Core 4 / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-3)]GalNAc
- O-Linked / Undefined core / Fuc(?1-2)[GalNAc(?1-3)]Gal(?1-?)GlcNAc(?1-?)Gal(?1-3)GalNAc
- O-Linked / Undefined core / Fuc(?1-2)[GlcNAc(?1-3)]Gal(?1-3)GlcNAc(?1-6)[Gal(?1-3)]GalNAc
- O-Linked / Undefined core / Fuc(?1-2)Gal(?1-?)GlcNAc(?1-6)[Gal(?1-?)GlcNAc(?1-3)]GalNAc
- Prostate cancer (DOID:10283)
- CD59 glycoprotein / Homo sapiens
- Uromodulin / Homo sapiens
- DLCNFNEQLENGGTSLSEK (19aa)
- ACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCKSNNGR (47aa)
- FALLMTNCYATPSSNATDPLKYFIIQDR (28aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:3 dHex:1 / O-Linked
(avg mass : 1098.0281)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Undefined core
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Undefined core
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Undefined core
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 4
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 4
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 4
(avg mass : 1098.0281)
Source
Reference
Reported glycosite
- O-Linked / Core 4
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 4
(avg mass : 1098.0281)
Reference
Reported glycosite
- O-Linked / Core 4
(avg mass : 1098.0281)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Disease
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 1
(avg mass : 1098.0281)
Source
Reported glycosite
- O-Linked / Core 1
(avg mass : 1098.0281)
Reported glycosite
- N-Linked / No-core
(avg mass : 1098.0281)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1098.0281)
Source
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1098.0281)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1098.0281)